knowledge -WSS

knowledge

author：fashion 2025-10-01 21:34:04 - browse：13441

A man enters the Regeneron Clinic at a monoclonal antibody treatment site in Pembroke Pines, Florida – politics and policy coverage from STAT — Regeneron agreed to price limits for a new Covid-19 drug that will be developed in partnership with the Department of Health and Human Services. CHANDAN KHANNA/AFP via Getty Images

WASHINGTON — A groundbreaking clause in a new deal between the Department of Health and Human Services and the pharmaceutical company Regeneron marks the first time the Biden administration has directly used its leverage to challenge drugmakers’ list prices, experts told STAT.

The contract between Regeneron and the government requires that the list price for a future monoclonal antibody drug to prevent Covid-19 is the same or lower in the United States as in other high-income countries. The release doesn’t explain which countries the government will be comparing prices with, or how pricing data will be determined.

The deal was part of the White House’s Project NextGen initiative, which includes $5 billion in new vaccines and therapies. HHS announced that it is spending $326 million to help Regeneron develop a new monoclonal antibody to prevent Covid-19. Regeneron in January announced plans to start testing a potentially variant-proof antibody, which is set to go into clinical trials later this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Hey, doctors: Don't be no

hotspot

WSS

Microsoft launches AI tool for clinical documentation through Epic

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

To bolster infectious disease surveillance, genomics powerhouses team up

New chief aims to remake Sanofi Genzyme

Head of FDA's diagnostics center, who led through Covid, retires

explore

knowledge

focus

Heart attack and stroke risk calculators need revising

TikTok, Instagram influencers need more rules for drug ads

Hepatitis C has a cure — but many Americans still lack access to it

HPV vaccine, cervical cancer study delivers historic results

Wildfire smoke exposes gaps in outdoor worker protections

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

As demand for Covid shots wanes, Moderna seeks its next success

Why the advice to take all your antibiotics may be wrong

Psychedelics group wrestles with new pharma identity

Biden White House, tech companies launch new safeguards around emerging AI technology

hotspot

What causes osteoarthritis? Researchers study link to brain protein

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

TikTok, Instagram influencers need more rules for drug ads

New chart reveals military’s vast involvement in Operation Warp Speed

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

A former Republican legislative candidate has been charged for his role in the US Capitol riot

hotspot

hotspot

leisure time

hotspot